Why it matters
Venture-funded SaaS companies rely heavily on equity awards (ESOPs) to attract talent while conserving cash, and a genuine P&L expense arises from grant date regardless of whether the company is private, pre-exit, or has never had a liquidity event; treating options as costless because no cash changes hands materially understates compensation expense and misleads on the true cost of the workforce, while misclassifying cash-settled or exit-contingent awards as equity-settled changes both measurement (fixed grant-date value versus remeasured fair value) and the balance between equity and liabilities.
Diagnostic questions
Are the equity awards equity-settled (settled by issuing shares) or cash-settled (e.g., phantom shares or stock appreciation rights), since this drives fundamentally different accounting? What service, market, or performance conditions attach to vesting, and are they reflected correctly in the fair value model versus the vesting-probability estimate? Is vesting contingent on an IPO or exit event, and if so, has expense recognition been deferred appropriately until that condition becomes probable? For a private company, what basis (e.g., a recent funding round valuation) supports the volatility and share price inputs to the option pricing model?
Recognition
- Classify the award as equity-settled (the entity settles by issuing its own equity instruments) or cash-settled (the entity settles in cash based on the value of equity instruments, e.g., phantom shares or stock appreciation rights), this classification drives fundamentally different subsequent accounting.
- For equity-settled awards, measure the fair value at grant date and do not remeasure it thereafter, regardless of how the entity's actual share value moves.
- Identify the vesting conditions: service conditions and non-market performance conditions affect the number of awards expected to vest (adjusted over the vesting period); market conditions (e.g., a share price target) are factored into the grant-date fair value itself and are not revisited even if not met.
- Recognize the compensation expense over the vesting period as services are rendered, with a corresponding credit to equity for equity-settled awards.
- For cash-settled awards, remeasure the liability to fair value at each reporting date until settlement, with changes recognized in profit or loss.
- Evaluate exit-contingent vesting (vesting only upon an IPO or change of control) carefully: if this is a non-vesting condition or if it represents a performance condition where the liquidity event is not considered probable, expense recognition may be deferred until the event becomes probable, but this requires careful analysis of the specific award terms rather than a blanket assumption of no expense.
Measurement
Measure equity-settled awards at grant-date fair value using an appropriate option pricing model (e.g., Black-Scholes or a binomial/lattice model), incorporating estimated volatility (for a private company, often derived from comparable listed peers), the risk-free rate, expected term, and expected dividend yield; this fair value is fixed and not remeasured, though the number of awards expected to vest is trued up over the vesting period for service and non-market performance conditions. Measure cash-settled awards at fair value at each reporting date and at settlement, recognizing the full remeasurement effect in profit or loss over the vesting period and beyond until settlement. Valuing equity in a private, pre-IPO company requires a defensible business valuation (e.g., using recent funding round pricing, discounted cash flow, or comparable company multiples) as an input, since no observable market price exists.
Presentation & disclosure
Disclose: a description of each type of share-based payment arrangement, including general terms and conditions (vesting requirements, maximum term, settlement method); the number and weighted-average exercise price of options outstanding, granted, exercised, forfeited, and expired during the period; the weighted-average fair value of options granted during the period and the valuation model and key inputs used (volatility, risk-free rate, expected term, dividend yield); total expense recognized in profit or loss for equity-settled and cash-settled arrangements, shown separately; the carrying amount of liabilities for cash-settled arrangements at period end.
Common mistakes
- Recording no expense at all because options are granted at a nominal or zero cash exercise price and '
- feel free'
- to the company
- treating phantom shares or stock appreciation rights (cash-settled by nature) as equity-settled and failing to remeasure them to fair value each period
- assuming no expense should be recognized for a private, pre-exit company simply because there is no listed share price or realized gain yet
- ignoring vesting condition mechanics by expensing the full grant-date value immediately instead of over the vesting period
- failing to obtain a defensible valuation of the underlying equity for a private company, leading to an unsupportable or stale fair value input.
Simple example
A private SaaS company grants an employee options over 40,000 shares, vesting evenly over 4 years (service condition only), with a grant-date fair value of SAR 10 per option determined using an option pricing model referencing a recent funding round valuation; total grant-date fair value is SAR 400,000, expensed straight-line over the 4-year vesting period (SAR 100,000 per year), with no remeasurement even though the company is private and pre-exit. Journal entry for year 1 expense: Dr Share-based payment expense (P&L) 100,000 Cr Equity - share-based payment reserve 100,000 If instead the award were phantom shares (cash-settled, paying the employee cash equal to the share value appreciation at vesting), the liability would be remeasured to fair value each period, e.g., if fair value increases and year 1's proportionate liability is now assessed at SAR 120,000: Dr Share-based payment expense (P&L) 120,000 Cr Share-based payment liability 120,000
Professional judgment
Valuing equity awards in a private company is inherently judgmental in the absence of an observable market price: volatility must be estimated from comparable listed peers, and the underlying equity value itself typically relies on the most recent funding round price, adjusted for the specific rights and preferences of the award class (e.g., ordinary shares versus preferred), which can differ materially in value. Determining whether an exit-contingent vesting condition (IPO or change of control) results in expense deferral requires careful reading of the award's specific mechanics, a condition drafted as a non-vesting condition, a performance condition, or simply a payment/settlement trigger can each produce different accounting outcomes for the same commercial intent, and this is one of the more contentious areas in practice, often warranting specialist valuation and accounting input.
Source basis
IFRS 2 · Share-based Payment
Paragraph references
Verified against the official standard texts used in the IFRS Expert skill.
Related issues
Educational and navigation content only. Not professional advice. Does not reproduce official IFRS/IAS text. Consult the authoritative standards and qualified professionals; professional judgment may still be required.
